All In MedTech

FDA Clearance Tracker · P890019

AB -HAVK

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Jul 13, 1990 (this decision)Source: openFDAMethods & limitations

PMA

The decision

FDA number
P890019
Device name
AB -HAVK
Applicant
Diasorin
Applicant location
Stillwater, MN
Received
Mar 15, 1989
Decided
Jul 13, 1990
Decision
Approved (reclassified)
Supplements
7 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class II
Regulation
21 CFR 866.3310

Every decision under product code LOL

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LOL. The earliest in FDA's data is P780012, decided Jan 19, 1979.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Diasorin

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.